Please Wait.....
Report
Bipolar Disorder Drugs and Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
Market Report I 2025-03-26 I 133 Pages I Global Market Insights
The Global Bipolar Disorder Drugs And Treatment Market was valued at USD 5.7 billion in 2024 and is projected to grow at a CAGR of 3.8% from 2025 to 2034. As mental health awareness continues to gain traction worldwide, the demand for medications to effectively manage bipolar disorder is on the rise. Bipolar disorder affects millions of individuals globally, leading to significant emotional, social, and occupational challenges. Increased public education initiatives, government funding, and advocacy efforts have driven a surge in early diagnosis and intervention. The growing acceptance of mental health as an essential component of overall well-being is motivating individuals to seek professional help, thus boosting the demand for effective treatment options. Furthermore, continuous advancements in pharmacological research are paving the way for the development of innovative therapies that cater to the diverse needs of patients. These treatments include atypical antipsychotics, mood stabilizers, and adjunctive therapies. Emerging trends such as artificial intelligence in drug discovery and wearable technology to monitor patient progress are enhancing treatment approaches, promising a future where data-driven and personalized care becomes the norm.
The market is segmented based on drug class, which includes anticonvulsants, antipsychotic drugs, mood stabilizers, antidepressant drugs, and anti-anxiety drugs. Among these, mood stabilizers dominate the segment, valued at USD 1.7 billion in 2024. These drugs play a crucial role in controlling mood swings and preventing manic or depressive episodes, which are essential for managing bipolar disorder. With continued improvements in drug efficacy and better dosage formulations, such as extended-release versions, patient adherence to treatment plans has significantly improved. Healthcare providers can now tailor dosages more effectively to meet individual patient needs, ultimately enhancing overall health outcomes. The demand for mood stabilizers continues to grow, reflecting the increasing awareness of bipolar disorder and the need for more effective and patient-friendly treatment options.
In terms of administration route, the market is categorized into oral, parenteral, and other methods. The oral segment accounted for 68.7% of the market share in 2024, primarily due to the convenience and effectiveness of oral medications. Oral treatments remain the preferred choice for managing bipolar disorder, as they are easy to administer and promote higher patient compliance. Advances in oral drug formulations, such as extended-release and combination therapies, have improved the effectiveness of these treatments, making them an attractive option for long-term maintenance therapy. The growing preference for oral medications, combined with continuous innovation in dosage forms, is expected to drive sustained growth in this segment.
The United States bipolar disorder drugs and treatment market is poised to generate USD 3.5 billion by 2034. The growth of the U.S. market is driven by high levels of awareness, an advanced healthcare infrastructure, and the increasing prevalence of bipolar disorder. Policies such as the Affordable Care Act have expanded access to mental health services, enabling more individuals to seek treatment and manage their conditions effectively. As healthcare providers adopt advanced technologies like telepsychiatry and AI-based tools for diagnosis and treatment, the demand for innovative therapies is expected to grow steadily. Additionally, U.S.-based pharmaceutical companies are leading the way in personalized medicine through genetic testing, allowing for more precise treatment options tailored to individual genetic profiles. This ongoing innovation is positioning the U.S. as a key player in the global bipolar disorder drugs and treatment market.
Report Content
Chapter 1 Methodology And Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing awareness of mental health conditions
3.2.1.2 Rising prevalence of bipolar disorders
3.2.1.3 Expanding government support for mental health
3.2.1.4 Integration of technological advancements
3.2.2 Industry pitfalls and challenges
3.2.2.1 Side effects of bipolar medication
3.2.2.2 Misdiagnosis of bipolar disorder
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 - 2034 ($ Mn)
5.1 Key trends
5.2 Mood stabilizers
5.3 Anticonvulsants
5.4 Anti-psychotic drugs
5.5 Anti-depressant drugs
5.6 Anti-anxiety drugs
5.7 Other drug classes
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn)
6.1 Key trends
6.2 Oral
6.3 Parenteral
6.4 Other routes of administration
Chapter 7 Market Estimates and Forecast, By Mechanism of Action, 2021 - 2034 ($ Mn)
7.1 Key trends
7.2 Selective serotonin reuptake inhibitors
7.3 Serotonin norepinephrine reuptake inhibitors
7.4 Tricyclic antidepressant drugs
7.5 Beta blockers
7.6 Other mechanisms of actions
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)
8.1 Key trends
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 AbbVie
10.2 AstraZeneca
10.3 Bristol-Myers Squibb
10.4 Eli Lilly
10.5 GlaxoSmithKline
10.6 Janssen Pharmaceuticals
10.7 Novartis
10.8 Otsuka Holdings
10.9 Pfizer
10.10 Sunovion Pharmaceuticals
10.11 Teva Pharmaceutical
10.12 Validus Pharmaceuticals
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security